Multiple SARS-CoV-2 Reinfections: A Case Series of Thrice-Infected Individuals

por Swift, Melanie D., Hainy, Caitlin M., Sampathkumar, Priya, Breeher, Laura E.
Publicado 2022

Disparities in COVID-19 vaccine uptake among health care workers

por Farah, Wigdan, Breeher, Laura, Shah, Vishal, Hainy, Caitlin, Tommaso, Christopher P., Swift, Melanie D.
Publicado 2022

Who is getting boosted? Disparities in COVID-19 vaccine booster uptake among health care workers

por Farah, Wigdan, Breeher, Laura E., Hainy, Caitlin M., Tommaso, Christopher P., Swift, Melanie D.
Publicado 2023

Revisiting the Safety of Health Care Workers

por Breeher, Laura E., Sampathkumar, Priya, Beam, Elena, Hainy, Caitlin M., Austin, Matthew D., Swift, Melanie D.
Publicado 2020

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area

por Shah, Vishal P., Hainy, Caitlin M., Swift, Melanie D., Breeher, Laura E., Theel, Elitza S., Sampathkumar, Priya
Publicado 2020

Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics

por Challener, Douglas W., Breeher, Laura E., Frain, JoEllen, Swift, Melanie D., Tosh, Pritish K., O’Horo, John
Publicado 2020

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

por Tande, Aaron J, Swift, Melanie D, Challener, Douglas W, Berbari, Elie F, Tommaso, Christopher P, Christopherson, Darrin R, Binnicker, Matthew J, Breeher, Laura E
Publicado 2022

Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare...

por Swift, Melanie D, Breeher, Laura E, Tande, Aaron J, Tommaso, Christopher P, Hainy, Caitlin M, Chu, Haitao, Murad, M Hassan, Berbari, Elie F, Virk, Abinash
Publicado 2021

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination

por Perez, Yalile, Levy, Emily R, Joshi, Avni Y, Virk, Abinash, Rodriguez-Porcel, Martin, Johnson, Matthew, Roellinger, Daniel, Vanichkachorn, Greg, Charles Huskins, W, Swift, Melanie D
Publicado 2021

Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy

por Finney Rutten, Lila J., Zhu, Xuan, Leppin, Aaron L., Ridgeway, Jennifer L., Swift, Melanie D., Griffin, Joan M., St Sauver, Jennifer L., Virk, Abinash, Jacobson, Robert M.
Publicado 2021

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

por Pawlowski, Colin, Lenehan, Patrick, Puranik, Arjun, Agarwal, Vineet, Venkatakrishnan, A.J., Niesen, Michiel J.M., O’Horo, John C., Virk, Abinash, Swift, Melanie D., Badley, Andrew D., Halamka, John, Soundararajan, Venky
Publicado 2021

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence

por Puranik, Arjun, Lenehan, Patrick J., Silvert, Eli, Niesen, Michiel J.M., Corchado-Garcia, Juan, O’Horo, John C., Virk, Abinash, Swift, Melanie D., Halamka, John, Badley, Andrew D., Venkatakrishnan, A.J., Soundararajan, Venky
Publicado 2021

Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System

por Pawlowski, Colin, Rincón-Hekking, John, Awasthi, Samir, Pandey, Viral, Lenehan, Patrick, Venkatakrishnan, AJ, Bade, Sairam, O'Horo, John C., Virk, Abinash, Swift, Melanie D., Williams, Amy W., Gores, Gregory J., Badley, Andrew D., Halamka, John, Soundararajan, Venky
Publicado 2021

Durability analysis of the highly effective BNT162b2 vaccine against COVID-19

por Puranik, Arjun, Lenehan, Patrick J, O'Horo, John C, Pawlowski, Colin, Niesen, Michiel J M, Virk, Abinash, Swift, Melanie D, Kremers, Walter, Venkatakrishnan, A J, Gordon, Joel E, Geyer, Holly L, Speicher, Leigh Lewis, Soundararajan, Venky, Badley, Andrew D
Publicado 2022

Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19

por Puranik, Arjun, Lenehan, Patrick J, O'Horo, John C, Pawlowski, Colin, Virk, Abinash, Swift, Melanie D, Kremers, Walter, Venkatakrishnan, A J, Challener, Doug W, Breeher, Laura, Gordon, Joel E, Geyer, Holly L, Speicher, Leigh Lewis, Soundararajan, Venky, Badley, Andrew D
Publicado 2022

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19

por Corchado-Garcia, Juan, Zemmour, David, Hughes, Travis, Bandi, Hari, Cristea-Platon, Tudor, Lenehan, Patrick, Pawlowski, Colin, Bade, Sairam, O’Horo, John C., Gores, Gregory J., Williams, Amy W., Badley, Andrew D., Halamka, John, Virk, Abinash, Swift, Melanie D., Wagner, Tyler, Soundararajan, Venky
Publicado 2021

Integrating Infectious Diseases and Preventive Medicine Specialties Into 1 Division: Experience of an Academic Medical Center

por Murad, M. Hassan, Swift, Melanie D., Razonable, Raymund R., Tande, Aaron J., Wilson, John W., Kasten, Mary J., Sia, Irene G., Matey, Jennifer N., Vanichkachorn, Greg, Caine, Natalie A., Shah, Vijay, O’Horo, Jack, Destro Borgen, Molly J., Cowl, Clayton T., Berbari, Elie F.
Publicado 2023

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

por Puranik, Arjun, Lenehan, Patrick J., Silvert, Eli, Niesen, Michiel J.M., Corchado-Garcia, Juan, O’Horo, John C., Virk, Abinash, Swift, Melanie D., Gordon, Joel E., Speicher, Leigh Lewis, Geyer, Holly L., Kremers, Walter, Halamka, John, Badley, Andrew D., Venkatakrishnan, A.J., Soundararajan, Venky
Publicado 2022

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records

por Niesen, Michiel J. M., Pawlowski, Colin, O’Horo, John C., Challener, Doug W., Silvert, Eli, Donadio, Greg, Lenehan, Patrick J., Virk, Abinash, Swift, Melanie D., Speicher, Leigh L., Gordon, Joel E., Geyer, Holly L., Halamka, John D., Venkatakrishnan, A. J., Soundararajan, Venky, Badley, Andrew D.
Publicado 2022

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients

por Chumsri, Saranya, Advani, Pooja P., Pai, Tanmayi S., Li, Zhuo, Mummareddy, Ashita, Acampora, Marites, Reynolds, Gina A., Wylie, Natasha, Boyle, Ashton W., Lou, Yanyan, Mody, Kabir, Moreno-Aspitia, Alvaro, Swift, Melanie D., Virk, Abinash, Bharucha, Adil E., Marquez, Christopher P., Patel, Tushar C., Gores, Gregory J., Knutson, Keith L.
Publicado 2021